may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful..

written reports, including local media accounts, professional medical papers and internal emails were also examined..

of the life claims declined, 0.85 per cent were due to mis-representation and 0.16 per cent due to the definition of terminal illness not being met. .